BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 179 found
  Current Search:  crestor: 179     

HTML
100%
FDA actions in brief, March 2010 (Iprivask, VPRIV, Mirapex ER, Cayston, Menveo, Lamictal XR, Rituxan, Oleptro, Xiaflex, Norvir, Benicar, Crestor)
Desirudin for injection (Iprivask, Canyon) was approved for the prevention of deep vein thrombosis.

Velaglucerase alfa for injection (VPRIV, Shire) was approved for the long-term treatment of type 1 Gaucher disease in pediatric and adult patients.

Modern Medicine:  Mar 20 2010 2:04PM
Matching: crestor
Find similar documents
HTML
100%
ACC: Chronic Kidney Disease Patients Fare Well in Statin Trial
Explain that this study appears to show safety of rosuvastatin in patients with chronic kidney disease.

Explain that there may be differences between patients with chronic kidney disease and those who have progressed to dialysis who may not benefit from...

MedPage Today:  Mar 19 2010 2:47AM
Matching: crestor
Find similar documents
HTML
100%
Rx Abandonment Rate Continues to Rise
The number of prescriptions filled in the retail sector was up 2.7 percent in 2009 from single digit growth in 2008.

Thats the good news.

The not-so-good news is that the number of scrips being filled for generics is beating branded drugs 2 to 1, and the...

Pharmaceutical Executive:  Mar 18 2010 2:08PM
Matching: crestor
Find similar documents
HTML
100%
Rx Abandonment Rate Continues to Rise
The number of prescriptions filled in the retail sector was up 2.7 percent in 2009 from single digit growth in 2008.

Thats the good news.

The not-so-good news is that the number of scrips being filled for generics is beating branded drugs 2 to 1, and the...

Pharmaceutical Executive:  Mar 18 2010 2:08PM
Matching: crestor
Find similar documents
HTML
100%
New drug could majorly reduce risk of heart disease
The cardiovascular disease rate was down 44 per cent in those using Crestor VANCOUVER (NEWS1130) - A new drug has been approved for use in Canada that can dramatically reduce the risk of heart disease.

The head of cardiology at McGill University, Dr.

News 1130:  Mar 18 2010 9:58AM
Matching: crestor
Find similar documents
HTML
100%
Shionogi looks to new products, in-house R&D to weather Crestor expiries
Shionogi is aiming to raise its consolidated net sales to 375 billion ($4.

Shionogi looks to new products, in-house R&D to weather Crestor expiries.

Scrip:  Mar 18 2010 3:00PM
Matching: crestor
Find similar documents
HTML
100%
AstraZeneca's CRESTOR: Health Canada approves new indication
Approval based on JUPITER trial which demonstrated reduction of cardiovascular events by nearly half AstraZeneca announced today that Health Canada has approved CRESTOR (rosuvastatin calcium) to reduce the risk of nonfatal myocardial infarction (heart...
News-Medical.Net:  Mar 17 2010 1:54PM
Matching: crestor
Find similar documents
HTML
100%
ONGLYZA-metformin combination: FDA accepts NDA for review
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S.

Food and Drug Administrat...Bristol-Myers Squibb to review key accomplishments at meeting with investment communityDuring a meeting with the investment community today, Bristol-Myers...

News-Medical.Net:  Mar 17 2010 1:47PM
Matching: crestor
Find similar documents
HTML
100%
Clinical Outcomes? Who Needs 'Em
'Welcome to the club.' -- Imaginary text message from Merck (NYSE: MRK) CEO Richard Clark to Abbott Labs (NYSE: ABT) CEO Miles White yesterday.

Like Merck's Zetia, Abbott's TriCor has been used by many patients, but neither drug has really been shown to do...

Cafepharma:  Mar 17 2010 8:00AM
Matching: crestor
Find similar documents
HTML
100%
Research and Markets: Atherosclerosis or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
Research and Markets: DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d0f918/atherosclerosis_or) has announced the addition of GlobalData's new report "" to their offering.

is an essential source of information and...

Yahoo! Canada:  Mar 17 2010 4:07PM
Matching: crestor
Find similar documents
HTML
100%
Clinical Outcomes? Who Needs 'Em.
"Welcome to the club." -- Imaginary text message from Merck (NYSE: MRK) CEO Richard Clark to Abbott Labs (NYSE: ABT) CEO Miles White yesterday.

Like Merck's Zetia, Abbott's TriCor has been used by many patients, but neither drug has really been shown to do...

Motley Fool via MSN Money:  Mar 15 2010 10:22PM
Matching: crestor
Find similar documents
HTML
100%
ACC: Triglycerides Decreased with Rosuvastatin Therapy
University of Pennsylvania School of Medicine.

Action Points Explain to interested patients that this study -- which specifically scrutinized the effects of statin therapy on triglycerides -- found that rosuvastatin (Crestor) significantly reduced the...

MedPage Today:  Mar 15 2010 7:15PM
Matching: crestor
Find similar documents
HTML
100%
Crestor, Plavix make new Chinese formulary
China is a promising new market for Big Pharma.

And when its government makes a healthcare-related move, the news reverberates throughout the drug industry.

Today, it's a good reverberation: China's National Reimbursement Drug List is being updated for the...

FiercePharma:  Mar 15 2010 6:02PM
Matching: crestor
Find similar documents
HTML
100%
FDA Conducts Review Of Study On Abbott's Trilipix
DOW JONES NEWSWIRES The U.S.

Food and Drug Administration said it will review data on Abbott Laboratories' (ABT) cholesterol drug Trilipix, which failed to significantly reduce the risk of heart attacks and strokes among diabetics in the so-called Accord...

Lloyd's:  Mar 15 2010 6:11PM
Matching: crestor
Find similar documents
HTML
100%
CORRECT: FDA TO Review Labeling Of Abbott's Trilipix
("FDA Conducts Review of Study On Abbott's Trilipix," published at 11:31 a.m.

EDT, incorrectly stated a study's link to Trilipix.

The Accord study addressed TriCor, while the Food and Drug Administration is addressing Trilipix.) DOW JONES NEWSWIRES The U.S....

Lloyd's:  Mar 15 2010 6:11PM
Matching: crestor
Find similar documents
HTML
100%
China Drug List Seen Boosting Western Firms' Sales
Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.

The National Reimbursement Drug List is being updated for the first...

Post Chronicle:  Mar 15 2010 5:29PM
Matching: crestor
Find similar documents
HTML
100%
CORRECT: FDA TO Review Labeling Of Abbott's Trilipix
('FDA Conducts Review of Study On Abbott's Trilipix,' published at 11:31 a.m.

EDT, incorrectly stated a study's link to Trilipix.

The Accord study addressed TriCor, while the Food and Drug Administration is addressing Trilipix.) DOW JONES NEWSWIRES The U.S....

Morningstar.com:  Mar 15 2010 5:27PM
Matching: crestor
Find similar documents
HTML
100%
FDA Conducts Review Of Study On Abbott's Trilipix
DOW JONES NEWSWIRES The U.S.

Food and Drug Administration said it will review data on Abbott Laboratories' (ABT) cholesterol drug Trilipix, which failed to significantly reduce the risk of heart attacks and strokes among diabetics in the so-called Accord...

Morningstar.com:  Mar 15 2010 5:26PM
Matching: crestor
Find similar documents
HTML
100%
FDA Conducts Review Of Study On Abbott's Trilipix
Dow Jones Newswires DOW JONES NEWSWIRES The U.S.

Food and Drug Administration said it will review data on Abbott Laboratories' (ABT) cholesterol drug Trilipix, which failed to significantly reduce the risk of heart attacks and strokes among diabetics in the...

FOXNews.com:  Mar 15 2010 5:09PM
Matching: crestor
Find similar documents
HTML
100%
CORRECT: FDA TO Review Labeling Of Abbott's Trilipix
("FDA Conducts Review of Study On Abbott's Trilipix," published at 11:31 a.m.

EDT, incorrectly stated a study's link to Trilipix.

The Accord study addressed TriCor, while the Food and Drug Administration is addressing Trilipix.) DOW JONES NEWSWIRES The U.S....

Nasdaq:  Mar 15 2010 4:59PM
Matching: crestor
Find similar documents
HTML
100%
FDA Conducts Review Of Study On Abbott's Trilipix
Dow Jones Newswires DOW JONES NEWSWIRES The U.S.

Food and Drug Administration said it will review data on Abbott Laboratories' (ABT) cholesterol drug Trilipix, which failed to significantly reduce the risk of heart attacks and strokes among diabetics in the...

FOXBusiness.com:  Mar 15 2010 4:55PM
Matching: crestor
Find similar documents
HTML
100%
China drug list seen boosting Western firms' sales
LONDON (Reuters) - Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.

The National Reimbursement Drug List is being...

Ottawa Citizen:  Mar 15 2010 1:48PM
Matching: crestor
Find similar documents
HTML
100%
China drug list seen boosting Western firms' sales
Tools and articles to help you manage your finances better The National Reimbursement Drug List is being updated for the first time since 2004 with many Western drugs added to the category that entitles patients to a rebate of up to 50 percent.

New entrants...

Reuters India:  Mar 15 2010 1:07PM
Matching: crestor
Find similar documents
HTML
100%
China drug list seen boosting Western firms' sales
LONDON (Reuters) - Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.

The National Reimbursement Drug List is being...

Reuters:  Mar 15 2010 1:02PM
Matching: crestor
Find similar documents
HTML
100%
China drug list seen boosting Western firms' sales
43 mins ago LONDON (Reuters) Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.

The National Reimbursement Drug List is...

AFP via Yahoo!:  Mar 15 2010 12:31PM
Matching: crestor
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.